OPKO Health (OPKO): CEO Takes Advantage of Consolidation to Purchase Shares Worth Approximately $2.99 Million!

OPKO Health (OPKO) focuses on next-generation solutions for serious diseases in established global markets. In the field of diagnostics, the company operates through its subsidiary BioReference Laboratories. BioReference Laboratories is one of the largest clinical laboratories in the USA, serving approximately 11 million patients annually. Main revenues come from diagnostic tests, especially in specialized areas such as oncology, infectious diseases, and women's health. During the COVID-19 pandemic, OPKO generated significant revenues from COVID-19...